Actively Recruiting
Open Vs. Endoscopic Transversus Abdominis Release Trial
Led by City Clinical Hospital No.1 named after N.I. Pirogov · Updated on 2024-12-18
36
Participants Needed
1
Research Sites
58 weeks
Total Duration
On this page
Sponsors
C
City Clinical Hospital No.1 named after N.I. Pirogov
Lead Sponsor
P
Pirogov Russian National Research Medical University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to comparatively evaluate the early and long-term results of open and endoscopic TAR procedure for large midline incisional ventral hernias.
CONDITIONS
Official Title
Open Vs. Endoscopic Transversus Abdominis Release Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Midline incisional hernia
- Hernia defect width from 8 to 12 cm
- ASA physical status class I to III
- Able to give informed consent
- Elective hernia repair planned
- Eligible for minimally invasive ventral hernia repair
You will not qualify if you...
- Primary ventral hernia
- Lateral hernia with or without midline involvement
- Refusal to give informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinical City Hospital #1 named after N.I. Pirogov
Moscow, Russia
Actively Recruiting
Research Team
A
Alexander Sazhin, professor
CONTACT
G
Georgy Ivakhov, professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here